Diagnosis and Management of Drug Induced Liver Injury (DILI) 2016 is a conference that covers topics such as:
- DILI clinical patterns and aetiological investigations
- Drug-Induced Liver Injuries
- Causality of DILI
- Specifically DILI during clinical trials and in post-marketing
Diagnosis and Management of Drug Induced Liver Injury (DILI) 2016 brings together healthcare professionals involved in the monitoring and assessment of Drug-Induced Liver Injury occurring in development or after marketing:
- People in charge of pharmacovigilance in regulatory authorities and in companies
- EU Qualified Persons for Pharmacovigilance
- Investigators
- Safety assessors in clinical trials and postmarketing
- Clinical Research Associates
